• News

"NIH Funding First Artificial Pancreas Study in Pregnant Women" - Regina Schaffer

  • Healio: Endocrine Today
  • New York, NY
  • (February 12, 2019)

A consortium of four leading institutions has begun enrolling women with type 1-diabetes for the first of several clinical trials designed to test the safety and efficacy of a closed-loop insulin delivery system adapted for pregnancy. The project is funded by a grant from the National Institutes of Health and includes researchers from the John A. Paulson School of Engineering and Applied Sciences at Harvard University, who will provide algorithm support, as well as a clinical research consortium of specialists from the Icahn School of Medicine at Mount Sinai, the Mayo Clinic and the Sansum Diabetes Research Institute. “The whole purpose of the closed loop is to allow a device to make more accurate dosing decisions in real time in a more efficient fashion than a patient can make,” said Carol Levy, MD, clinical director of the Mount Sinai Diabetes Center and a principal investigator for the project. ”Many pregnant women work very hard to manage their blood sugar, but still struggle with highs and lows.”

— Carol J. Levy, MD, Clinical Director, Mount Sinai Diabetes Center, Associate Professor, Medicine, Endocrinology, Diabetes, Bone Disease, Icahn School of Medicine at Mount Sinai

Learn more